Yan Fong Lam
Corporate Officer/Principal en Lam & Co. .
Cargos activos de Yan Fong Lam
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Lam & Co.
Lam & Co. Food: Meat/Fish/DairyConsumer Non-Durables Lam & Co. is a Singaporean company that specializes in ice cream and frozen desserts. The private company is based in Singapore, Singapore. The company was founded by Philip Lam, who has been the CEO since incorporation. | Corporate Officer/Principal | 01/01/2007 | - |
Historial de carrera de Yan Fong Lam
Antiguos cargos conocidos de Yan Fong Lam.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SOUTH SHORE HOLDINGS LIMITED | Director/Miembro de la Junta | 18/05/2021 | 02/09/2021 |
Independent Dir/Board Member | 18/05/2021 | 02/09/2021 | |
KING INTERNATIONAL INVESTMENT LIMITED | Director/Miembro de la Junta | 15/08/2011 | 19/05/2014 |
Independent Dir/Board Member | 15/08/2011 | 19/05/2014 | |
GOLDSTONE INVESTMENT GROUP LIMITED | Director/Miembro de la Junta | 20/10/2011 | 01/11/2013 |
Independent Dir/Board Member | 20/10/2011 | 01/11/2013 | |
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Director/Miembro de la Junta | 20/05/2016 | - |
RENTIAN TECHNOLOGY HOLDINGS LIMITED | Director/Miembro de la Junta | 18/05/2007 | - |
Independent Dir/Board Member | 18/05/2007 | - |
Formación de Yan Fong Lam.
University of Hong Kong | Graduate Degree |
Estadísticas
Internacional
Hong-Kong | 7 |
Singapur | 2 |
Operativa
Director/Board Member | 5 |
Independent Dir/Board Member | 4 |
Graduate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Electronic Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
KING INTERNATIONAL INVESTMENT LIMITED | Health Technology |
GOLDSTONE INVESTMENT GROUP LIMITED | Finance |
SOUTH SHORE HOLDINGS LIMITED | Industrial Services |
Empresas privadas | 3 |
---|---|
Rentian Technology Holdings Ltd.
Rentian Technology Holdings Ltd. Computer Processing HardwareElectronic Technology Rentian Technology Holdings Ltd. is an investment company. It operates through the following segments: Human-Machine Interactive Devices (HMID), Internet-of-things Solution, Intelligent Documentation Service (IDS), and Investing. The Human-Machine Interactive Devices segment relates to the development of terminal hardware, software and services application for treasury and taxation, finance, education, and other key industries. The Internet-of-things Solution segment refers to cloud computing and data processing and analysis; telecommunication infrastructure and technologies; and terminal computing for corporate internet-of-things systems. The Intelligent Documentation Service segment provides specialized services to accelerate document-driven business processes. The Investing segment refers to investment in mid and small caps. The company was founded on September 10, 1998 and is headquartered in Hong Kong. | Electronic Technology |
Lam & Co.
Lam & Co. Food: Meat/Fish/DairyConsumer Non-Durables Lam & Co. is a Singaporean company that specializes in ice cream and frozen desserts. The private company is based in Singapore, Singapore. The company was founded by Philip Lam, who has been the CEO since incorporation. | Consumer Non-Durables |
Mingyuan Medicare Development Co. Ltd.
Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
- Bolsa de valores
- Insiders
- Yan Fong Lam
- Experiencia